Skip to main content
OpenTrials
Completed

NCT Number: NCT01049321

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

44 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Shahid motahari hospital, Esfahan Esteel company, Iran

Isfahan, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having type 2 diabetes

Exclusion criteria

  • Having other chronic disease, hepatic or kidney disorders, cancer, hormone therapy

Treatment and study plan

DASH diet

Dietary Supplement

Other names: Dietary aproaches to stop hypertension

a usual diabetic diet

Dietary Supplement

Primary outcomes

  1. Cardio-metabolic risks

    Time frame: 6 months

Secondary outcomes

  1. Hepatic function

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Isfahan University of Medical Sciences

Other

Collaborators

  • Shahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, Isfahan

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Jan 14, 2010
Registry last updated
Jan 14, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.